Citations

Mayo Clinic

Showing 10 of 108523 citations.

A Systematic Review of Clinical Outcomes and Prognostic Factors for Patients Undergoing Surgery for Spinal Metastases Secondary to Breast Cancer
Sciubba, Daniel M. , Yurter, Alp, Ju, Derek G. , Gokaslan, Ziya L. , Fisher, Charles G. , Rhines, Laurence D. , Fourney, Daryl R. , Mendel, Ehud , Laufer, Ilya , Patel, Shreyaskumar , Rampersaud, Y. Raja , Chou, Dean , Weber, Michael H. , Fehlings, Michael G. , Bettegowda, Chetan , Goodwin, C. Rory , Reynolds, Jeremy , Clarke, Michelle J.

Global Spine Journal | May 18, 2015 | Volume: 5 | Issue: 1_suppl | Pages: s-0035-1554402-s-0035-1554402

10.1055/s-0035-1554402 Get It

Introduction Surgical treatment and cement augmentation procedures are effective palliative techniques for the treatment of symptomatic spinal metastases. However, clinical results specific to a breast cancer cohort are generally lacking. We aim to systematically review the literature for clinical outcomes following operative interventions and prognostic factors for the treatment of breast metastases to the spine. Specifically, we describe the survival and clinical outcomes of surgery and cement augmentation procedures for breast metastases to the spine and to determine prognostic variables that may help recognize which patients will perform better or worse following surgery. Methods We performed a literature review using PubMed to identify articles that reported outcomes and/or prognostic factors of the breast cancer patient population with spinal metastases treated with any surgical technique since 1990. Results A total of 19 surgical studies, 4 cement augmentation studies, and 6 nonsurgical prognostic variable studies met the preset inclusion criteria. All but three studies (two surgical and one cement augmentation) were retrospective in nature, and all studies were of level of evidence IV. Median postoperative survival for metastatic breast cancer was 21.7 months (8.2–36 months), mean rate of pain improvement was 92.9% (76–100%), mean rate of neurological improvement was 63.8% (53–100%), mean rate neurological decline was 4.1% (0–8%), and mean rate LTC was 92.6% (89–100%). Kyphoplasty studies reported a high rate of pain control in selected patients. Negative prognostic variables included: hormonal (estrogen and progesterone) and HER2 receptor refractory tumor status, high degree of axillary lymph node involvement, and short disease-free interval (DFI). All other clinical or prognostic parameters were of low or insufficient strength. Conclusion With respect to clinical outcomes, studies consistently found that surgery resulted in neurological improvement for a majority of patients, with a minimal risk of worsening, and kyphoplasty studies reported a high rate of pain control. Increased postoperative survival 2002 onwards was likely due to FDA approval of new chemotherapies. However, specific factors associated with shorter survival following surgery involve hormone and HER2 receptor status and disease-free interval.
Osteosarcoma of the Spine: Prognostic Variables for Local Recurrence and Overall Survival, A Multicenter Ambispective Study
Dekutoski, Mark B. , Rhines, Laurence D. , Rose, Peter S. , Fisher, Charles G. , Chou, Dean , Reynolds, Jeremy , Williams, Richard , Quraishi, Nasir A. , Germscheid, Niccole, Sciubba, Daniel M. , Gokaslan, Ziya L. , Clarke, Michelle J. , Luzzati, Alessandro , Varga, Péter , Fehlings, Michael G. , Boriani, Stefano

Global Spine Journal | May 18, 2015 | Volume: 5 | Issue: 1_suppl | Pages: s-0035-1554214-s-0035-1554214

10.1055/s-0035-1554214 Get It

Introduction Primary spinal osteosarcomas are rare and aggressive neoplasms with poor outcomes. Enneking appropriate, en bloc resection is recommended for appendicular osteosarcomas. Obtaining even marginal margins is technically demanding in the spine, resulting in significant morbidity and possible functional sacrifice. The aim of this study was to identify prognostic variables on local recurrence and mortality, in surgically treated patients diagnosed with a primary osteosarcoma of the spine. Methods A multicenter ambispective database of surgically treated patients with primary spine osteosarcomas was developed by the AOSpine knowledge forum tumor. Patient demographic, diagnosis, treatment, perioperative morbidity, local recurrence, and cross-sectional survival data were collected. Tumors were classified according to Enneking principles and analyzed in the following two cohorts: Enneking appropriate (EA) and Enneking inappropriate (EI). EA was defined by the final pathology margin matching the Enneking recommended surgical margin and EI by not matching. Prognostic variables including age, previous spine tumor operation, biopsy type, spine level, tumor size, and chemotherapy timing were analyzed in reference to local recurrence and survival. Results Between 1987 and 2012, 57 patients (31 females and 26 males) underwent surgical treatment for a primary spinal osteosarcoma at a mean age of 36 ± 16 years. Patients were followed for a mean period of 3.4 ± 3.5 years (range, 0.5 days–14.3 years). Median survival for the entire cohort was 6.7 years postoperative. Overall, 24 (42%) patients died and 17 (30%) patients suffered a local recurrence, 10 (59%) of which died. Overall, 28 (52%) patients underwent EA resection while 26 (48%) patients were treated by EI resection. Median survival for patients with EA was 6.8 years postoperative, whereas median survival for EI patients was 3.7 years postoperatively ( p = 0.062). EI patients were at a higher risk of local recurrence than EA patients ( p = 0.002). Patient age, previous spine tumor operation, tumor size, spine level, and chemotherapy timing did not significantly influence recurrence and survival. Conclusion Osteosarcoma of the spine presents a significant challenge and most patients die from their disease in spite of aggressive surgery. There is a significant decrease in recurrence with en bloc resection when compared with intralesional resection.
A 53‐Year‐Old Man With Dysuria, Pyuria, and Genital Ulcers
Jimenez, Xavier , Psutka, Sarah P. , Stone, John H. , Carruthers, Mollie N. , Psutka, Sarah P

Arthritis Care & Research | May 18, 2015 | Volume: 68 | Issue: 9 | Pages: 1371-1377

10.1002/acr.22617 | PMID 25989159 Get It

A 50‐Year‐Old Woman With Cowden Syndrome and Joint Pains
Bond, Jeffrey R., Chowdhary, Vaidehi , Sagar, Vinay, Chowdhary, Vaidehi R, Sagar, Vinay

Arthritis Care & Research | May 18, 2015 | Volume: 67 | Issue: 11 | Pages: 1604-1608

10.1002/acr.22616 | PMID 25989067 Get It

Low‐density lipoprotein‐cholesterol (LDL‐C) greater than 100 mg/dL as a quality indicator: locating risk in person, place and time
Rohrer, James E. , Doğaner, Yusuf Çetin , Merry, Stephen , Angstman, Kurt B. , Erickson, Jacob L. , Furst, Joseph W. , Doganer, Yusuf C, Merry, Stephen P, Merry, Stephen P

Journal of Evaluation in Clinical Practice | May 18, 2015 | Volume: 21 | Issue: 4 | Pages: 735-739

10.1111/jep.12378 | PMID 25988919 Get It

AbstractRationale, aims and objectivesAchieving control over elevated lipid parameters, particularly low‐density lipoprotein (LDL)‐cholesterol, is an acknowledged quality indicator in primary care. The Centers for Disease Control and Prevention (CDC)'s model for investigation of outbreaks (person–place–time) can be applied to the analysis of quality indicators.MethodsA sample of 322 family medicine patients for whom lipid levels were ordered was extracted. LDL > 100 mg/dL was cross‐tabulated by personal characteristics [age group, gender, body mass index (BMI), diagnoses], month (time) and ordering department (place).ResultsAge (except one age category), gender, time and location were not related to LDL > 100 mg/dL after adjustment for covariates. All levels of BMI above normal elevated the risk of LDL > 100 mg/dL [BMI 25–29.9: odds ratio (OR) = 3.41, confidence interval (CI) = 1.61–7.23, P = 0.0014; BMI 30–34.9: OR = 2.93, CI = 1.28–6.70, P = 0.0109; BMI ≥ 35: OR = 2.75, CI = 1.19–6.37, P = 0.0181]. Patients with coronary artery disease (CAD) and diabetes mellitus (DM) were at reduced risk for LDL > 100 mg/dL (CAD: OR = 0.47, CI = 0.24–0.91, P = 0.0254; DM: OR = 0.28, CI = 0.14–0.55, P = 0.0002).ConclusionAn outbreak investigation model is useful for analysing variations in this quality indicator. Patients with higher BMI and those not diagnosed with CAD or DM type I/II may be considered for intensified lipid lowering using quality improvement efforts. These might include counselling for lifestyle changes or medication therapy depending upon their calculated cardiac risk.
Biology‐Driven Gene‐Gene Interaction Analysis of Age‐Related Cataract in the eMERGE Network
Hall, Molly A. , Wallace, John R. , Lucas, Anastasia, Berg, Richard L. , Connolly, John J. , Crawford, Dana C. , Crosslin, David R. , Doheny, Kimberly F. , Haines, Jonathan L. , Harley, John B. , Jarvik, Gail P. , Kitchner, Terrie, Kuivaniemi, Helena , Larson, Eric B. , Tromp, Gerard , Vrabec, Tamara R. , Pendergrass, Sarah A. , McCarty, Catherine A. , Ritchie, Marylyn D. , de Andrade, Mariza, Verma, Shefali S. , Andrade, Mariza de , Carrell, David , Jarvik, Gail P , Connolly, John J

Genetic Epidemiology | May 18, 2015 | Volume: 39 | Issue: 5 | Pages: 376-384

10.1002/gepi.21902 | PMID 25982363 Get It

ABSTRACTBioinformatics approaches to examine gene‐gene models provide a means to discover interactions between multiple genes that underlie complex disease. Extensive computational demands and adjusting for multiple testing make uncovering genetic interactions a challenge. Here, we address these issues using our knowledge‐driven filtering method, Biofilter, to identify putative single nucleotide polymorphism (SNP) interaction models for cataract susceptibility, thereby reducing the number of models for analysis. Models were evaluated in 3,377 European Americans (1,185 controls, 2,192 cases) from the Marshfield Clinic, a study site of the Electronic Medical Records and Genomics (eMERGE) Network, using logistic regression. All statistically significant models from the Marshfield Clinic were then evaluated in an independent dataset of 4,311 individuals (742 controls, 3,569 cases), using independent samples from additional study sites in the eMERGE Network: Mayo Clinic, Group Health/University of Washington, Vanderbilt University Medical Center, and Geisinger Health System. Eighty‐three SNP‐SNP models replicated in the independent dataset at likelihood ratio test P < 0.05. Among the most significant replicating models was rs12597188 (intron of CDH1)–rs11564445 (intron of CTNNB1). These genes are known to be involved in processes that include: cell‐to‐cell adhesion signaling, cell‐cell junction organization, and cell‐cell communication. Further Biofilter analysis of all replicating models revealed a number of common functions among the genes harboring the 83 replicating SNP‐SNP models, which included signal transduction and PI3K‐Akt signaling pathway. These findings demonstrate the utility of Biofilter as a biology‐driven method, applicable for any genome‐wide association study dataset.
The Authors Reply: “Association of face‐to‐face handoffs and outcomes of hospitalized internal medicine patients”
Schouten, Will M. , Burton, M. Caroline , Jones, LaKisha D., Newman, James S. , Kashiwagi, Deanne T. , Newman, James

Journal of Hospital Medicine | May 18, 2015 | Volume: 10 | Issue: 8 | Pages: 559-559

10.1002/jhm.2383 | PMID 25980952 Get It

Baseline Perineural Invasion is Associated with Shorter Time to Progression in Men with Prostate Cancer Undergoing Active Surveillance: Results from the REDEEM Study
Moreira, Daniel M. , Fleshner, Neil , Freedland, Stephen J.

Journal of Urology | May 16, 2015 | Volume: 194 | Issue: 5 | Pages: 1258-1263

10.1016/j.juro.2015.04.113 | PMID 25988518 Get It

Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia
Greenwood‐Quaintance, Kerryl E. , Karau, Melissa J. , Tilahun, Ashenafi Y. , Khaleghi, Shahryar, Chowdhary, Vaidehi , David, Chella S., Patel, Robin , Rajagopalan, Govindarajan , Chung, Jin-Won, Tilahun, Ashenafi, Khaleghi, Shahryar Rostamkolaei, Chowdhary, Vaidehi R, Chung, Jin-Won , Patel, Robin

Journal of Leukocyte Biology | May 16, 2015 | Volume: 98 | Issue: 2 | Pages: 271-281

10.1189/jlb.4a1214-577rr | PMID 25979434 Get It

Abstract SAgs, produced by Staphylococcus aureus, play a major role in the pathogenesis of invasive staphylococcal diseases by inducing potent activation of the immune system. However, the role of SAgs, produced by S. aureus, associated with indwelling devices or tissues, are not known. Given the prevalence of device-associated infection with toxigenic S. aureus in clinical settings and the potency of SAgs, we hypothesized that continuous exposure to SAgs produced by catheter-associated S. aureus could have systemic consequences. To investigate these effects, we established a murine in vivo catheter colonization model. One centimeter long intravenous catheters were colonized with a clinical S. aureus isolate producing SAgs or isogenic S. aureus strains, capable or incapable of producing SAg. Catheters were subcutaneously implanted in age-matched HLA-DR3, B6, and AEo mice lacking MHC class II molecules and euthanized 7 d later. There was no evidence of systemic infection. However, in HLA-DR3 transgenic mice, which respond robustly to SSAgs, the SSAg-producing, but not the nonproducing strains, caused a transient increase in serum cytokine levels and a protracted expansion of splenic CD4+ T cells expressing SSAg-reactive TCR Vβ8. Lungs, livers, and kidneys from these mice showed infiltration with CD4+ and CD11b+ cells. These findings were absent in B6 and AEo mice, which are known to respond poorly to SSAgs. Overall, our novel findings suggest that systemic immune activation elicited by SAgs, produced by S. aureus colonizing foreign bodies, could have clinical consequences in humans.
Patient Activity and Survival Following Implantable Cardioverter‐Defibrillator Implantation: The ALTITUDE Activity Study
Kramer, Daniel B. , Mitchell, Susan L., Jones, Paul W. , Normand, Sharon‐Lise T. , Hayes, David L. , Reynolds, Matthew R. , Monteiro, João P.

Journal of the American Heart Association | May 16, 2015 | Volume: 4 | Issue: 5 | Pages: No page available

10.1161/jaha.115.001775 | PMID 25979902 Get It

Background Physical activity data are collected automatically by implantable cardioverter‐defibrillators ( ICD s). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its relationship with survival has not been well studied. Methods and Results Patients enrolled in the Boston Scientific LATITUDE remote monitoring system from 2008 to 2012 with ICD s were eligible. Remote monitoring data were used to calculate mean daily activity at baseline (30 to 60 days after implantation), and longitudinally. Cox regression was used to examine the association between survival and increments of 30 minutes/day in both (1) mean baseline activity and (2) time‐varying activity, with both adjusted for demographic and device characteristics. A total of 98 437 patients were followed for a median of 2.2 years (mean age of 67.7±13.1 years; 71.7% male). Mean baseline daily activity was 107.5±66.2 minutes/day. The proportion of patients surviving after 4 years was significantly higher among those in the most versus least active quintile of mean baseline activity (90.5% vs. 50.0%; log‐rank P value, <0.001). Lower mean baseline activity (i.e., incremental difference of 30‐minutes/day) was independently associated with a higher risk of death (adjusted hazard ratio [ AHR ], 1.44; 95% confidence interval [ CI ], 1.427 to 1.462). Time‐varying activity was similarly associated with a higher risk of death ( AHR , 1.48; 95% CI , 1.451 to 1.508), indicating that a patient having 30 minutes per day less activity in a given month has a 48% increased hazard for death when compared to a similar patient in the same month. Conclusions Patient activity measured by ICD s strongly correlates with survival following ICD implantation.